BALTIMORE, Sept. 6, 2018 /PRNewswire/ -- Today at
GRx + Biosims: Engineering the Future of Generic + Biosimilar
Medicines, the Association for Accessible Medicines' (AAM)
annual industry conference, a panel that examined prescription
medicine access for patients who are uninsured, underinsured or
affected by disasters was led by Amalia
Adler-Waxman, VP, Social Impact & Responsibility, Teva
Pharmaceuticals; Direct Relief's Director of US Programs,
Damon Taugher and Malvise A. Scott,
Senior VP Partnership and Resource Development, National
Association of Community Health Centers (NACHC).
Over 1,000 leaders participated in this highly-regarded
conference with the goal of sharing relevant news, best practices
and meaningful insights taking place within the pharmaceutical
industry. AAM continues to seek to improve access to
prescription medicines; many of its members are among generous
donors of essential and specialty medicines required for good
health.
With over 100 corporate healthcare partners, Direct Relief
collaborates with numerous AAM member companies. The organizations'
generous donations of prescription medicines allow access for
underserved patients who would likely go without otherwise.
"Generic chronic disease medicines are critically important for
the health of uninsured and underserved patients, as well as those
impacted by natural disasters or emergencies, and Direct Relief is
deeply grateful for the donations it receives from generic
manufacturers of high-quality, FDA-approved medicines," said
Taugher, speaking on today's AAM panel. "Support from generic
pharmaceutical companies like Teva Pharmaceuticals results in
improved care for patients at Direct Relief's safety-net partners
in the US and across a vast network of public hospitals and clinics
globally."
Teva Pharmaceuticals is the world's leading generic
pharmaceuticals company and has a long and impressive history of
corporate social responsibility by providing both financial and
prescription product support to its partners. Adler-Waxman
said, "Teva takes its commitment to continue to improve access to
affordable quality medicines seriously. Our product donations
are pivotal to this commitment and we accomplish this by donating
viable and requested medicines to our medical relief partners that
have been fully vetted, audited and qualified to properly handle,
store, distribute and report on the humanitarian product donations
that we provide."
Adler-Waxman added, "Direct Relief has been Teva's principal
partner over the past decade in which our medical products have
been jointly provided to improve care for the underserved in 86
countries, including in the US." This program also supports Teva's
contribution to addressing the rising burden of NCDs, where many of
its donated products ensure access to those suffering from CVD,
diabetes, respiratory diseases, cancer, pain as well as
antibiotics."
Teva and Direct Relief have also worked together to advance best
practices and innovation around improved care for Multiple Chronic
Conditions patients and are developing tools to help safety-net
providers in the US and internationally to better care for their
patients with more than one chronic
disease.
Ms. Scott commented, "NACHC is grateful for the significant
commitment that Teva and Direct Relief have made to provide vital
medicines to so many of our community health centers. These
donated medicines make a vital difference in restoring the health
of millions of underserved American patients who have diseases such
as diabetes, hypertension, and respiratory illness and that lack
prescription insurance or financial means." With a membership
of over 1,400 health center member entities, NACHC affiliated
health centers care for over 28 million uninsured or underinsured
Americans with primary care services, as well as various specialty
medical services depending on the individual
clinic.
About Direct Relief
Established in 1948 with a mission
to improve the health and lives of people affected by poverty or
emergencies, Direct Relief delivers lifesaving medical resources
throughout the world—without regard to politics, religion, ethnic
identities, or ability to pay. With operations spanning more than
70 countries and all 50 states in the U.S., Direct Relief is the
only charitable nonprofit to obtain Verified Accredited Wholesale
Distributor (VAWD) accreditation by the National Association of
Boards of Pharmacy. Among other distinctions, Direct Relief earns a
perfect score of 100 from independent evaluator Charity Navigator,
was listed among the world's most innovative nonprofits by Fast
Company, and has received the CECP Directors' Award, the Drucker
Prize for Nonprofit Innovation, and the President's Award from Esri
for excellence in GIS mapping. For more information, please
visit https://www.directrelief.org/
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE
and TASE: TEVA) is a global leader in generic medicines, with
innovative treatments in select areas, including CNS, pain and
respiratory. We deliver high-quality generic products and medicines
in nearly every therapeutic area to address unmet patient needs. We
have an established presence in generics, specialty, OTC and API,
building on more than a century-old legacy, with a fully integrated
R&D function, strong operational base and global infrastructure
and scale. We strive to act in a socially and environmentally
responsible way. Headquartered in Israel, with production and research
facilities around the globe, we employ 45,000 professionals,
committed to improving the lives of millions of patients. Learn
more at www.tevapharm.com.
About NACHC
The National Association of Community
Health Centers was founded in 1971, with a mission to promote the
provision of high quality, comprehensive and affordable health care
that is coordinated, culturally and linguistically competent, and
community directed for all medically underserved populations. NACHC
is the membership organization for community health centers
nationwide, which provide primary and preventive health care to
over to 28 million people from more than 10,000
sites. www.nachc.org
View original content with
multimedia:http://www.prnewswire.com/news-releases/teva-nachc-and-direct-relief-provide-important-insights-on-prescription-medicine-access-for-underserved-patients-at-the-aam-conference-300708424.html
SOURCE Direct Relief